Second Genome Competitors and Similar CompaniesClear all

Second Genome's competitors and similar companies include PanTheryx, TeselaGen Biotechnology and Healx.
Second Genome
Second Genome
Second Genome is a company that specializes in the development of biotechnology research transformational precision therapies.
PanTheryx
PanTheryx
PanTheryx is a medical nutrition company focused on the research, development, and commercialization of products that promote intestinal health.
TeselaGen Biotechnology
TeselaGen Biotechnology
TeselaGen Biotechnology is an AI-based platform that provides product development of therapeutics.
Healx
Healx
Healx is an AI technology company accelerating the discovery and development of rare disease treatments.
Founding Date
Founding Date
2009
Founding Date
2007
Founding Date
2011
Founding Date
2014
Type
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Brisbane, US HQ
Locations
Boulder, US HQ
Boulder, US
Phoenix, US
Ripon, US
Locations
Portola Valley, US HQ
Santiago, CL
Locations
Cambridge, GB HQ
Employees
Employees
713% decrease
Employees
267% decrease
Employees
27
Employees
683% decrease

Funding

Latest funding round
Latest funding round
$ 8.4m (almost 10 years ago)
Latest funding round
$ 50m (about 7 years ago)
Latest funding round
$ 2m (over 8 years ago)
Latest funding round
$ 56m (over 6 years ago)
Total funding raised
Total funding raised
$ 76.5m
Total funding raised
$ 137m
Total funding raised
$ 3.3m
Total funding raised
$ 66m
For sources of this data, please see the company profile

View Company Profiles

PanTheryx
HQ
Boulder, US
Employees
26↓ 7% decrease

PanTheryx is a medical nutrition company focused on the research, development, and commercialization of products that promote intestinal health.

View company
TeselaGen Biotechnology
HQ
Portola Valley, US
Employees
27

TeselaGen Biotechnology is an AI-based platform that provides product development of therapeutics.

View company
Healx
HQ
Cambridge, GB
Employees
68↓ 3% decrease

Healx is an AI technology company accelerating the discovery and development of rare disease treatments.

View company